These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18499496)

  • 1. [Hydroxyurea treatment in patients affected with sickle cell anemia: efficacy and safety].
    de Montalembert M
    Transfus Clin Biol; 2008; 15(1-2):34-8. PubMed ID: 18499496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Terrin ML; Moore RD; Dover GJ; Barton FB; Eckert SV; McMahon RP; Bonds DR
    N Engl J Med; 1995 May; 332(20):1317-22. PubMed ID: 7715639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of hydroxyurea in children with sickle cell disease: what comes next?
    Ohene-Frempong K; Smith-Whitley K
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):30-41. PubMed ID: 9317199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea as treatment for sickle cell anemia.
    Charache S
    Hematol Oncol Clin North Am; 1991 Jun; 5(3):571-83. PubMed ID: 1713911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea in the treatment of sickle-cell anemia.
    Howard LW; Kennedy LD
    Ann Pharmacother; 1997 Nov; 31(11):1393-6. PubMed ID: 9391697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes.
    de Montalembert M; Brousse V; Elie C; Bernaudin F; Shi J; Landais P;
    Haematologica; 2006 Jan; 91(1):125-8. PubMed ID: 16434381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea in sickle cell disease: What will it take to change practice?
    Atweh GF
    Am J Hematol; 2010 Jun; 85(6):401-2. PubMed ID: 20513115
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of clinical response by hydroxyurea in 132 patients with major sickle cell anemia].
    Elira Dokekias A; Okandze Elenga JP; Ndinga J; Sanogo I; Sangare A
    Tunis Med; 2005 Jan; 83(1):32-7. PubMed ID: 15881719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical follow-up of hydroxyurea-treated adults with sickle cell disease.
    Nzouakou R; Bachir D; Lavaud A; Habibi A; Lee K; Lionnet F; Hulin A; Jouault H; Préhu C; Roudot-Thoraval F; Girot R; Galactéros F
    Acta Haematol; 2011; 125(3):145-52. PubMed ID: 21196716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of hydroxyurea on hemoglobin S].
    Torres AF; Eberle SE; Sciuccati G; Bonduel M
    Medicina (B Aires); 2003; 63(2):140-2. PubMed ID: 12793083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea in children: present and future.
    Vichinsky EP
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):22-9. PubMed ID: 9317198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hydroxyurea and other agents stimulating synthesis of fetal hemoglobin].
    de Montalembert M
    Pathol Biol (Paris); 1999 Jan; 47(1):55-8. PubMed ID: 10081780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of sickle cell disease patients with priapism treated by hydroxyurea.
    Saad ST; Lajolo C; Gilli S; Marques Júnior JF; Lima CS; Costa FF; Arruda VR
    Am J Hematol; 2004 Sep; 77(1):45-9. PubMed ID: 15307105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin's disease in a child with sickle cell disease treated with hydroxyurea.
    Moschovi M; Psychou F; Menegas D; Tsangaris GT; Tzortzatou-Stathopoulou F; Nicolaidou P
    Pediatr Hematol Oncol; 2001 Sep; 18(6):371-6. PubMed ID: 11554231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxurea and sickle cell disease: Its been a long, long time coming.
    Scott JP
    Pediatr Blood Cancer; 2010 Feb; 54(2):185-6. PubMed ID: 19908298
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
    Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea in sickle cell disease patients from Eastern Saudi Arabia.
    Al-Jam'a AH; Al-Dabbous IA
    Saudi Med J; 2002 Mar; 23(3):277-81. PubMed ID: 11938415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males.
    Berthaut I; Guignedoux G; Kirsch-Noir F; de Larouziere V; Ravel C; Bachir D; Galactéros F; Ancel PY; Kunstmann JM; Levy L; Jouannet P; Girot R; Mandelbaum J
    Haematologica; 2008 Jul; 93(7):988-93. PubMed ID: 18508803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N
    Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of hydroxyurea in severe forms of sickle cell disease: study of 47 Tunisian paediatric cases].
    Mellouli F; Bejaoui M
    Arch Pediatr; 2008 Jan; 15(1):24-8. PubMed ID: 18164913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.